ABSTRACT
In selection of the right treatment for a specific patient, the surgeon should consider not only the best approach to remove a tumor but also the impact of treatment on the quality of life (QOL) of the patient. Procedures involving extirpation of skull base tumors may be associated with high morbidity. It is therefore important to study patients with skull base neoplasms, because survival differences between various treatment modalities may be small, yet larger differences are expected regarding morbidity. The overall QOL in the majority of patients after skull base tumor resection can be classified as “good,” with significant improvement taking place within 12 months following surgery. Patients with carcinomas, acoustic schwannoma, or Cushing's disease suffer from more significant deterioration in their QOL after any intervention. Data retrieved from disease-specific questionnaires revealed that the financial and emotional domains have the worse impact on patients QOL. Old age, malignancy, comorbidity, radiotherapy, and extensive surgery were found to be also negative prognostic factors for QOL. Pain control regimens, antidepressants, and other psychological modalities, including group support, can improve QOL measures in these patients. It is critical that surgeons understand that they cannot assess their patients' perspectives on QOL correctly without asking them. For adequate assessment, validated disease-specific instruments addressing multiple domains of QOL should be utilized.
KEYWORDS
Quality of life - cranial base - craniofacial - cancer - neurosurgery
REFERENCES
-
1
Gil Z, Abergel A, Spektor S et al..
Quality of life following surgery for anterior skull base tumors.
Arch Otolaryngol Head Neck Surg.
2003;
129
1303-1309
-
2
Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss D M.
Development of a cancer-specific anterior skull base quality-of-life questionnaire.
J Neurosurg.
2004;
100
813-819
-
3
Gil Z, Patel S G, Singh B International Collaborative Study Group et al.
Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study.
Cancer.
2007;
110
1033-1041
-
4
Langendijk H, Aaronson N K, de Jong J M, ten Velde G P, Muller M J, Wouters M.
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.
Radiother Oncol.
2000;
55
19-25
-
5
Movsas B.
Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01.
Semin Radiat Oncol.
2002;
12(1, Suppl 1)
40-45
-
6
Sanda M G, Dunn R L, Michalski J et al..
Quality of life and satisfaction with outcome among prostate-cancer survivors.
N Engl J Med.
2008;
358
1250-1261
-
7
Fliss D M, Abergel A, Cavel O, Margalit N, Gil Z.
Combined subcranial approaches for excision of complex anterior skull base tumors.
Arch Otolaryngol Head Neck Surg.
2007;
133
888-896
-
8
Janecka I P, Sen C, Sekhar L N et al..
Cranial base surgery: results in 183 patients.
Otolaryngol Head Neck Surg.
1994;
110
539-546
-
9
Gil Z, Abergel A, Spektor S, Khafif A, Fliss D M.
Patient, caregiver, and surgeon perceptions of quality of life following anterior skull base surgery.
Arch Otolaryngol Head Neck Surg.
2004;
130
1276-1281
-
10
Fukuda K, Saeki N, Mine S et al..
Evaluation of outcome and QOL in patients with craniofacial resection for malignant tumors involving the anterior skull base.
Neurol Res.
2000;
22
545-550
-
11
Hahn C A, Dunn R H, Logue P E, King J H, Edwards C L, Halperin E C.
Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors.
Int J Radiat Oncol Biol Phys.
2003;
55
992-999
-
12
Martinez-Devesa P, Barnes M L, Alcock C J, Kerr R S, Milford C A.
Evaluation of quality of life and psychiatric morbidity in patients with malignant tumours of the skull base.
J Laryngol Otol.
2006;
120
1049-1054
-
13
Mohsenipour I, Deusch E, Gabl M, Hofer M, Twerdy K.
Quality of life in patients after meningioma resection.
Acta Neurochir (Wien).
2001;
143
547-553
-
14
De Jesús O, Sekhar L N, Parikh H K, Wright D C, Wagner D P.
Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life.
Neurosurgery.
1996;
39
915-919
discussion 919-920
-
15
Lang D A, Neil-Dwyer G, Garfield J.
Outcome after complex neurosurgery: the caregiver's burden is forgotten.
J Neurosurg.
1999;
91
359-363
-
16
Nikolopoulos T P, Johnson I, O'Donoghue G M.
Quality of life after acoustic neuroma surgery.
Laryngoscope.
1998;
108
1382-1385
-
17
Tufarelli D, Meli A, Alesii A et al..
Quality of life after acoustic neuroma surgery.
Otol Neurotol.
2006;
27
403-409
-
18
da Cruz M J, Moffat D A, Hardy D G.
Postoperative quality of life in vestibular schwannoma patients measured by the SF36 Health Questionnaire.
Laryngoscope.
2000;
110
151-155
-
19
Baumann I, Polligkeit J, Blumenstock G, Mauz P S, Zalaman I M, Maassen M M.
Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach.
Acta Otolaryngol.
2005;
125
585-591
-
20
Irving R M, Beynon G J, Viani L, Hardy D G, Baguley D M, Moffat D A.
The patient's perspective after vestibular schwannoma removal: quality of life and implications for management.
Am J Otol.
1995;
16
331-337
-
21
Myrseth E, Møller P, Pedersen P H, Vassbotn F S, Wentzel-Larsen T, Lund-Johansen M.
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery.
Neurosurgery.
2005;
56
927-935
discussion 927-935
-
22
Sandooram D, Grunfeld E A, McKinney C, Gleeson M J.
Quality of life following microsurgery, radiosurgery and conservative management for unilateral vestibular schwannoma.
Clin Otolaryngol Allied Sci.
2004;
29
621-627
-
23
Ryzenman J M, Pensak M L, Tew Jr J M.
Headache: a quality of life analysis in a cohort of 1,657 patients undergoing acoustic neuroma surgery, results from the acoustic neuroma association.
Laryngoscope.
2005;
115
703-711
-
24
Betchen S A, Walsh J, Post K D.
Self-assessed quality of life after acoustic neuroma surgery.
J Neurosurg.
2003;
99
818-823
-
25
Briner H R, Linder T E, Pauw B, Fisch U.
Long-term results of surgery for temporal bone paragangliomas.
Laryngoscope.
1999;
109
577-583
-
26
Bülow B, Hagmar L, Ørbaek P, Osterberg K, Erfurth E M.
High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease.
Clin Endocrinol (Oxf).
2002;
56
183-193
-
27
Page R C, Hammersley M S, Burke C W, Wass J A.
An account of the quality of life of patients after treatment for non-functioning pituitary tumours.
Clin Endocrinol (Oxf).
1997;
46
401-406
-
28
Grattan-Smith P J, Morris J G, Shores E A, Batchelor J, Sparks R S.
Neuropsychological abnormalities in patients with pituitary tumours.
Acta Neurol Scand.
1992;
86
626-631
-
29
Peace K A, Orme S M, Padayatty S J, Godfrey H P, Belchetz P E.
Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication.
Clin Endocrinol (Oxf).
1998;
49
391-396
-
30
Peace K A, Orme S M, Sebastian J P et al..
The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease.
Clin Endocrinol (Oxf).
1997;
46
445-450
-
31
Heald A H, Ghosh S, Bray S et al..
Long-term negative impact on quality of life in patients with successfully treated Cushing's disease.
Clin Endocrinol (Oxf).
2004;
61
458-465
-
32
Lindsay J R, Nansel T, Baid S, Gumowski J, Nieman L K.
Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission.
J Clin Endocrinol Metab.
2006;
91
447-453
-
33
Peace K A, Orme S M, Thompson A R, Padayatty S, Ellis A W, Belchetz P E.
Cognitive dysfunction in patients treated for pituitary tumours.
J Clin Exp Neuropsychol.
1997;
19
1-6
-
34
Noad R, Narayanan K R, Howlett T, Lincoln N B, Page R C.
Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life.
Clin Oncol (R Coll Radiol).
2004;
16
233-237
-
35
van Beek A P, van den Bergh A C, van den Berg L M et al..
Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma.
Int J Radiat Oncol Biol Phys.
2007;
68
986-991
-
36
Karavitaki N, Brufani C, Warner J T et al..
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Clin Endocrinol (Oxf).
2005;
62
397-409
-
37
Kendall-Taylor P, Jönsson P J, Abs R et al..
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Eur J Endocrinol.
2005;
152
557-567
-
38
Pereira A M, Schmid E M, Schutte P J et al..
High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
Clin Endocrinol (Oxf).
2005;
62
197-204
-
39
Dekkers O M, Biermasz N R, Smit J W et al..
Quality of life in treated adult craniopharyngioma patients.
Eur J Endocrinol.
2006;
154
483-489
-
40
Müller H L, Bruhnken G, Emser A et al..
Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma.
Childs Nerv Syst.
2005;
21
975-980
-
41
Villani R M, Tomei G, Bello L et al..
Long-term results of treatment for craniopharyngioma in children.
Childs Nerv Syst.
1997;
13
397-405
-
42
Poretti A, Grotzer M A, Ribi K, Schönle E, Boltshauser E.
Outcome of craniopharyngioma in children: long-term complications and quality of life.
Dev Med Child Neurol.
2004;
46
220-229
-
43
Gil Z, Smith D B, Marouani N, Khafif A, Fliss D M.
Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries.
Otolaryngol Head Neck Surg.
2006;
135
182-188
-
44
Bardiau F M, Taviaux N F, Albert A, Boogaerts J G, Stadler M.
An intervention study to enhance postoperative pain management.
Anesth Analg.
2003;
96
179-185
-
45
Massie M J.
Prevalence of depression in patients with cancer.
J Natl Cancer Inst Monogr.
2004;
(32)
57-71
-
46
Fisch M J, Loehrer P J, Kristeller J Hoosier Oncology Group et al.
Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
J Clin Oncol.
2003;
21
1937-1943
-
47
Razavi D, Allilaire J F, Smith M et al..
The effect of fluoxetine on anxiety and depression symptoms in cancer patients.
Acta Psychiatr Scand.
1996;
94
205-210
-
48
Williams S, Dale J.
The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review.
Br J Cancer.
2006;
94
372-390
-
49
Barsevick A M, Sweeney C, Haney E, Chung E.
A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer.
Oncol Nurs Forum.
2002;
29
73-84
, quiz 85–87
-
50
Spiegel D, Butler L D, Giese-Davis J et al..
Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.
Cancer.
2007;
110
1130-1138
-
51
Fawzy F I, Fawzy N W, Hyun C S et al..
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.
Arch Gen Psychiatry.
1993;
50
681-689
-
52
Richardson J L, Shelton D R, Krailo M, Levine A M.
The effect of compliance with treatment on survival among patients with hematologic malignancies.
J Clin Oncol.
1990;
8
356-364
-
53
Fliss D M, Zucker G, Cohen A et al..
Early outcome and complications of the extended subcranial approach to the anterior skull base.
Laryngoscope.
1999;
109
153-160
-
54
Winzelberg A J, Classen C, Alpers G W et al..
Evaluation of an internet support group for women with primary breast cancer.
Cancer.
2003;
97
1164-1173
Ziv GilM.D. Ph.D.
Skull Base Surgery Service, Department of Otolaryngology–Head and Neck Surgery, Tel-Aviv Sourasky Medical Center
6 Weizman Street, Tel Aviv 64239, Israel
eMail: ziv@baseofskull.org
